Regeneron: Driven by Science

For over 25 years, Regeneron's vision has been to build an innovative company that consistently brings new medicines to patients with serious diseases.

Recent News

Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration


TARRYTOWN, N.Y. and PARIS, July 28, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)  and Sanofi have entered into a new global collaboration to discover, develop and commercialize new antibody cancer treatments in the emerging field of immuno-oncology. As part of the agreement, t...

Read more

Upcoming Events

Regeneron Pharmaceuticals Q2 2015 Earnings Conference Call

08/04/15 at 8:30 AM ET

View Event

Form content here please :)